Phase II study on DuP 937 (Teloxantrone) in colorectal carcinoma. A Canadian National Cancer Institute Clinical Trial Group study

  • Invest New Drugs. 1993 May-Aug;11(2-3):235-7. doi: 10.1007/BF00874163.
J A Maroun  1 ,  J Skillings ,  R MacCormick ,  M Potvin ,  G Wielgosz ,  J R Davidson ,  E Eisenhauer
Affiliations
  • 1. Ottawa Regional Cancer Centre, Canada.
PMID: 8262739 DOI: 10.1007/BF00874163
Products